Literature DB >> 12714029

Congenital heart disease: the original heart failure syndrome.

Aidan P Bolger1, Andrew J S Coats, Michael A Gatzoulis.   

Abstract

Heart failure is characterised by a triad comprising cardiac abnormality, exercise limitation and neurohormonal activation. The 2% of the adult population who suffer with heart failure are known to derive both symptomatic and prognostic benefit from exercise and pharmacologic neurohormonal antagonism. The existence of heart failure has traditionally been considered in the context of ischaemic, hypertensive, valvular and myopathic disease but in this article we develop the argument that patients with congenital heart disease also manifest all the pathophysiological criteria that constitute the chronic heart failure syndrome. We discuss the inherent limitations to a purely anatomical approach to congenital heart disease, bring attention to the large and rapidly growing population of adults with this condition and conclude by calling for a therapeutic approach to congenital heart disease that is based on the heart failure paradigm.

Entities:  

Mesh:

Year:  2003        PMID: 12714029     DOI: 10.1016/s0195-668x(03)00005-8

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  23 in total

1.  A specified therapeutic window for neuregulin-1 to regenerate neonatal heart muscle.

Authors:  Federica Santoro; Makoto Sahara
Journal:  Ann Transl Med       Date:  2015-10

2.  Neuregulin stimulation of cardiomyocyte regeneration in mice and human myocardium reveals a therapeutic window.

Authors:  Brian D Polizzotti; Balakrishnan Ganapathy; Stuart Walsh; Sangita Choudhury; Niyatie Ammanamanchi; David G Bennett; Cristobal G dos Remedios; Bernhard J Haubner; Josef M Penninger; Bernhard Kühn
Journal:  Sci Transl Med       Date:  2015-04-01       Impact factor: 17.956

Review 3.  Management of Heart Failure in Adult Congenital Heart Disease.

Authors:  Aarthi Sabanayagam; Omer Cavus; Jordan Williams; Elisa Bradley
Journal:  Heart Fail Clin       Date:  2018-08-20       Impact factor: 3.179

Review 4.  Burden of Heart Failure in Adults with Congenital Heart Disease.

Authors:  Laith I Alshawabkeh; Alexander R Opotowsky
Journal:  Curr Heart Fail Rep       Date:  2016-10

Review 5.  Myocardial factor revisited: The importance of myocardial fibrosis in adults with congenital heart disease.

Authors:  Craig S Broberg; Luke J Burchill
Journal:  Int J Cardiol       Date:  2015-04-10       Impact factor: 4.164

6.  Prognostic value of multiple biomarkers for cardiovascular mortality in adult congenital heart disease: comparisons of single-/two-ventricle physiology, and systemic morphologically right/left ventricles.

Authors:  Kenji Miyamoto; Daiji Takeuchi; Kei Inai; Tokuko Shinohara; Toshio Nakanishi
Journal:  Heart Vessels       Date:  2016-02-08       Impact factor: 2.037

7.  Quantification of diffuse myocardial fibrosis and its association with myocardial dysfunction in congenital heart disease.

Authors:  Craig S Broberg; Sumeet S Chugh; Catherine Conklin; David J Sahn; Michael Jerosch-Herold
Journal:  Circ Cardiovasc Imaging       Date:  2010-09-20       Impact factor: 7.792

8.  Predicting Outcomes Using the Heart Failure Survival Score in Adults with Moderate or Complex Congenital Heart Disease.

Authors:  Elaine Y Lin; Hillel W Cohen; Ami B Bhatt; Ada Stefanescu; David Dudzinski; Doreen DeFaria Yeh; Jacob Johnson; George K Lui
Journal:  Congenit Heart Dis       Date:  2014-10-31       Impact factor: 2.007

9.  Kidney Outcomes 5 Years After Pediatric Cardiac Surgery: The TRIBE-AKI Study.

Authors:  Jason H Greenberg; Michael Zappitelli; Prasad Devarajan; Heather R Thiessen-Philbrook; Catherine Krawczeski; Simon Li; Amit X Garg; Steve Coca; Chirag R Parikh
Journal:  JAMA Pediatr       Date:  2016-11-01       Impact factor: 16.193

10.  Organ allocation in adults with congenital heart disease listed for heart transplant: impact of ventricular assist devices.

Authors:  Jill M Gelow; Howard K Song; Joseph B Weiss; James O Mudd; Craig S Broberg
Journal:  J Heart Lung Transplant       Date:  2013-08-06       Impact factor: 10.247

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.